![W. Keith Schilit](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
W. Keith Schilit
Career history of W. Keith Schilit
Former positions of W. Keith Schilit
Companies | Position | Start | End |
---|---|---|---|
MIGENIX, Inc.
![]() MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Director/Board Member | 18/11/2004 | - |
Training of W. Keith Schilit
University of Maryland | Doctorate Degree |
Statistics
International
Canada | 2 |
United States | 2 |
Operational
Director/Board Member | 1 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
MIGENIX, Inc.
![]() MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- W. Keith Schilit
- Experience